{"id":4883,"date":"2024-02-21T19:23:25","date_gmt":"2024-02-21T11:23:25","guid":{"rendered":"https:\/\/regask.com\/?p=4883"},"modified":"2024-11-05T20:53:46","modified_gmt":"2024-11-05T12:53:46","slug":"sante-canada-revise-le-code-de-publicite-pharmaceutique","status":"publish","type":"post","link":"https:\/\/regask.com\/fr\/health-canada-review-pharma-advertising-code\/","title":{"rendered":"Modifications propos\u00e9es \u00e0 l\u2019avis sur la publicit\u00e9 pharmaceutique\u2026"},"content":{"rendered":"<div class=\"ewa-rteLine\">\n<div class=\"ewa-rteLine\">\n<div class=\"ewa-rteLine\">\n<div class=\"ewa-rteLine\">\n<div class=\"ewa-rteLine\">\n<div class=\"ewa-rteLine\">\n<div class=\"ewa-rteLine\">\n<div class=\"ewa-rteLine\">\n<div class=\"ewa-rteLine\">Sant\u00e9 Canada examine actuellement une refonte importante des normes de publicit\u00e9 pharmaceutique propos\u00e9e par le Conseil consultatif de publicit\u00e9 pharmaceutique (CCPP).<\/div>\n<div><\/div>\n<div class=\"ewa-rteLine\">L\u2019accent est mis en priorit\u00e9 sur la modernisation de l\u2019approche des donn\u00e9es probantes issues du monde r\u00e9el (RWE). Le projet de document d\u2019orientation sur les RWE, \u00e9labor\u00e9 gr\u00e2ce \u00e0 une collaboration approfondie avec l\u2019industrie, pr\u00e9sente un cadre transparent et fond\u00e9 sur des donn\u00e9es probantes pour l\u2019inclusion des RWE dans la publicit\u00e9 destin\u00e9e aux professionnels de la sant\u00e9.<\/div>\n<div><\/div>\n<div class=\"ewa-rteLine\">Les modifications propos\u00e9es visent \u00e0 \u00e9largir les crit\u00e8res d&#039;admissibilit\u00e9 des r\u00e9sultats d&#039;essais cliniques, avec des crit\u00e8res rigoureux de qualit\u00e9 et de pertinence des preuves. La refonte s&#039;\u00e9tend \u00e9galement aux crit\u00e8res des essais cliniques, autorisant les crit\u00e8res d&#039;\u00e9valuation subjectifs et assouplissant les exigences de correspondance des formulations pour les essais d&#039;autres juridictions.<\/div>\n<div><\/div>\n<div class=\"ewa-rteLine\">Pour une analyse d\u00e9taill\u00e9e, explorez la comparaison du texte tabul\u00e9 des sections actuelles et propos\u00e9es du Code.<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<div>\n\t<div id=\"gap-961769460\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-961769460 {\n  padding-top: 40px;\n}\n<\/style>\n\t<\/div>\n\t\n\n\t<div id=\"col-443768234\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<a href=\"https:\/\/www.paab.ca\/resources\/draft-code-change-currently-undergoing-health-canada-review\/\" target=\"_blank\" class=\"button secondary is-link\" rel=\"noopener\" >\n\t\t<span>En savoir plus<\/span>\n\t<\/a>\n\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\n\t\n<a href=\"https:\/\/regask.com\/fr\/contact-2\/\" class=\"button secondary\" style=\"border-radius:10px;\">\n\t\t<span>Un soutien en mati\u00e8re de renseignements r\u00e9glementaires \u00e0 port\u00e9e de main<\/span>\n\t<\/a>\n\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>Sant\u00e9 Canada examine actuellement une refonte importante des normes en mati\u00e8re de publicit\u00e9 pharmaceutique propos\u00e9e par le Conseil consultatif de la publicit\u00e9 pharmaceutique (CCPP). L\u2019objectif principal est de moderniser l\u2019approche relative aux donn\u00e9es probantes en situation r\u00e9elle (DPR). L\u2019\u00e9bauche du document d\u2019orientation sur les DPR, \u00e9labor\u00e9e gr\u00e2ce \u00e0 une vaste collaboration avec l\u2019industrie, d\u00e9crit un cadre transparent et fond\u00e9 sur des donn\u00e9es probantes pour l\u2019int\u00e9gration des DPR dans la publicit\u00e9 destin\u00e9e aux professionnels de la sant\u00e9.<\/p>","protected":false},"author":39,"featured_media":7393,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[513,35],"tags":[335,387],"class_list":["post-4883","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-canada-regulations","category-pharma-biotech-latest-insights","tag-advertising-regulations","tag-real-word-evidence-rwe"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.3 (Yoast SEO v28.3) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Health Canada Review: Overhauling Pharmaceutical Advertising<\/title>\n<meta name=\"description\" content=\"Learn about expanded acceptance of Real-World Evidence, proposed adjustments to clinical trial criteria... Read more | RegASK\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/regask.com\/fr\/sante-canada-revise-le-code-de-publicite-pharmaceutique\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Proposed changes to the Pharmaceutical Advertising Advisory Board (PAAB) Code undergoing Health Canada Review\" \/>\n<meta property=\"og:description\" content=\"Learn about expanded acceptance of Real-World Evidence, proposed adjustments to clinical trial criteria... Read more | RegASK\" \/>\n<meta property=\"og:url\" content=\"https:\/\/regask.com\/fr\/sante-canada-revise-le-code-de-publicite-pharmaceutique\/\" \/>\n<meta property=\"og:site_name\" content=\"RegASK\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-02-21T11:23:25+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-11-05T12:53:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/regask.com\/wp-content\/uploads\/2021\/12\/food-with-trans-fat-fop-labelling.png\" \/>\n\t<meta property=\"og:image:width\" content=\"688\" \/>\n\t<meta property=\"og:image:height\" content=\"626\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Benoit Trouwaert\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/regask.com\/wp-content\/uploads\/2021\/12\/food-with-trans-fat-fop-labelling.png\" \/>\n<meta name=\"twitter:creator\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:site\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Benoit Trouwaert\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/regask.com\\\/health-canada-review-pharma-advertising-code\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/health-canada-review-pharma-advertising-code\\\/\"},\"author\":{\"name\":\"Benoit Trouwaert\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/person\\\/c1d261e8dcf7b1c30b2c4f2c119df42d\"},\"headline\":\"Proposed changes to the Pharmaceutical Advertising Advi&hellip;\",\"datePublished\":\"2024-02-21T11:23:25+00:00\",\"dateModified\":\"2024-11-05T12:53:46+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/health-canada-review-pharma-advertising-code\\\/\"},\"wordCount\":162,\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/health-canada-review-pharma-advertising-code\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/proposed-changes-pharmaceutical-advertising-advisory-board-paab-code-health-canada-review.png\",\"keywords\":[\"Advertising Regulations\",\"Real-Word-Evidence (RWE)\"],\"articleSection\":[\"Canada\",\"Pharma and Biotech\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/regask.com\\\/health-canada-review-pharma-advertising-code\\\/\",\"url\":\"https:\\\/\\\/regask.com\\\/health-canada-review-pharma-advertising-code\\\/\",\"name\":\"Health Canada Review: Overhauling Pharmaceutical Advertising\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/health-canada-review-pharma-advertising-code\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/health-canada-review-pharma-advertising-code\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/proposed-changes-pharmaceutical-advertising-advisory-board-paab-code-health-canada-review.png\",\"datePublished\":\"2024-02-21T11:23:25+00:00\",\"dateModified\":\"2024-11-05T12:53:46+00:00\",\"description\":\"Learn about expanded acceptance of Real-World Evidence, proposed adjustments to clinical trial criteria... Read more | RegASK\",\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/regask.com\\\/health-canada-review-pharma-advertising-code\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/regask.com\\\/health-canada-review-pharma-advertising-code\\\/#primaryimage\",\"url\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/proposed-changes-pharmaceutical-advertising-advisory-board-paab-code-health-canada-review.png\",\"contentUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/proposed-changes-pharmaceutical-advertising-advisory-board-paab-code-health-canada-review.png\",\"width\":1600,\"height\":1200,\"caption\":\"Proposed Changes Pharmaceutical Advertising Advisory Board Paab Code Health Canada Review\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/regask.com\\\/#website\",\"url\":\"https:\\\/\\\/regask.com\\\/\",\"name\":\"RegASK\",\"description\":\"The Regulatory AI Operating System for High-Performing Teams\",\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/regask.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\",\"name\":\"RegASK\",\"url\":\"https:\\\/\\\/regask.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/RegASK-Logo-Dark-Round.png\",\"contentUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/RegASK-Logo-Dark-Round.png\",\"width\":401,\"height\":401,\"caption\":\"RegASK\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/RegASKRegulatoryAffairs\\\/\",\"https:\\\/\\\/x.com\\\/ASKRegASK\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/RegASK\\\/\",\"https:\\\/\\\/www.youtube.com\\\/@RegASK\",\"https:\\\/\\\/www.crunchbase.com\\\/organization\\\/regask\",\"https:\\\/\\\/www.bloomberg.com\\\/profile\\\/company\\\/1691237D:SP\",\"https:\\\/\\\/pitchbook.com\\\/profiles\\\/company\\\/265004-02\",\"https:\\\/\\\/www.cbinsights.com\\\/company\\\/RegASK\",\"https:\\\/\\\/vimeo.com\\\/RegASK\"],\"legalName\":\"RegASK PTE. LTD.\",\"foundingDate\":\"2018\",\"slogan\":\"Empowering Smarter Regulatory Decisions\",\"description\":\"Agentic AI regulatory intelligence and workflow orchestration platform for Life Sciences and Consumer Products. RegASK combines vertical LLMs, multi-agent AI architecture, and a global community of 1,800+ subject matter experts to deliver regulatory horizon scanning, impact analysis, compliance workflow automation, and audit-ready outputs across 160+ countries.\",\"areaServed\":\"Worldwide\",\"founder\":{\"@type\":\"Person\",\"name\":\"Caroline Shleifer\",\"jobTitle\":\"Founder & CEO\"},\"address\":{\"@type\":\"PostalAddress\",\"streetAddress\":\"79 Science Park Drive, #06-01, Cintech IV\",\"addressLocality\":\"Singapore\",\"postalCode\":\"118264\",\"addressCountry\":\"SG\"},\"contactPoint\":{\"@type\":\"ContactPoint\",\"telephone\":\"+65 6817 6290\",\"contactType\":\"customer service\",\"availableLanguage\":[\"English\",\"French\",\"Japanese\",\"Spanish\",\"Chinese\",\"German\"]},\"numberOfEmployees\":{\"@type\":\"QuantitativeValue\",\"minValue\":50,\"maxValue\":100},\"knowsAbout\":[\"Regulatory Intelligence\",\"Regulatory Compliance\",\"Regulatory Affairs\",\"Workflow Orchestration\",\"Life Sciences Regulation\",\"Consumer Products Regulation\",\"AI-Driven Compliance\"],\"hasCertification\":[{\"@type\":\"Certification\",\"name\":\"ISO\\\/IEC 42001:2023\"},{\"@type\":\"Certification\",\"name\":\"ISO\\\/IEC 27001:2022\"},{\"@type\":\"Certification\",\"name\":\"ISO\\\/IEC 27701\"},{\"@type\":\"Certification\",\"name\":\"ISO\\\/IEC 27018:2019\"},{\"@type\":\"Certification\",\"name\":\"SOC 2 Type II\"}]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/person\\\/c1d261e8dcf7b1c30b2c4f2c119df42d\",\"name\":\"Benoit Trouwaert\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Examen de Sant\u00e9 Canada : refonte de la publicit\u00e9 pharmaceutique","description":"Apprenez-en plus sur l&#039;acceptation \u00e9largie des preuves du monde r\u00e9el, les ajustements propos\u00e9s aux crit\u00e8res des essais cliniques... Lire la suite | RegASK","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/regask.com\/fr\/sante-canada-revise-le-code-de-publicite-pharmaceutique\/","og_locale":"fr_FR","og_type":"article","og_title":"Proposed changes to the Pharmaceutical Advertising Advisory Board (PAAB) Code undergoing Health Canada Review","og_description":"Learn about expanded acceptance of Real-World Evidence, proposed adjustments to clinical trial criteria... Read more | RegASK","og_url":"https:\/\/regask.com\/fr\/sante-canada-revise-le-code-de-publicite-pharmaceutique\/","og_site_name":"RegASK","article_publisher":"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/","article_published_time":"2024-02-21T11:23:25+00:00","article_modified_time":"2024-11-05T12:53:46+00:00","og_image":[{"width":688,"height":626,"url":"https:\/\/regask.com\/wp-content\/uploads\/2021\/12\/food-with-trans-fat-fop-labelling.png","type":"image\/png"}],"author":"Benoit Trouwaert","twitter_card":"summary_large_image","twitter_image":"https:\/\/regask.com\/wp-content\/uploads\/2021\/12\/food-with-trans-fat-fop-labelling.png","twitter_creator":"@ASKRegASK","twitter_site":"@ASKRegASK","twitter_misc":{"Written by":"Benoit Trouwaert","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/regask.com\/health-canada-review-pharma-advertising-code\/#article","isPartOf":{"@id":"https:\/\/regask.com\/health-canada-review-pharma-advertising-code\/"},"author":{"name":"Benoit Trouwaert","@id":"https:\/\/regask.com\/#\/schema\/person\/c1d261e8dcf7b1c30b2c4f2c119df42d"},"headline":"Proposed changes to the Pharmaceutical Advertising Advi&hellip;","datePublished":"2024-02-21T11:23:25+00:00","dateModified":"2024-11-05T12:53:46+00:00","mainEntityOfPage":{"@id":"https:\/\/regask.com\/health-canada-review-pharma-advertising-code\/"},"wordCount":162,"publisher":{"@id":"https:\/\/regask.com\/#organization"},"image":{"@id":"https:\/\/regask.com\/health-canada-review-pharma-advertising-code\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2024\/02\/proposed-changes-pharmaceutical-advertising-advisory-board-paab-code-health-canada-review.png","keywords":["Advertising Regulations","Real-Word-Evidence (RWE)"],"articleSection":["Canada","Pharma and Biotech"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/regask.com\/health-canada-review-pharma-advertising-code\/","url":"https:\/\/regask.com\/health-canada-review-pharma-advertising-code\/","name":"Examen de Sant\u00e9 Canada : refonte de la publicit\u00e9 pharmaceutique","isPartOf":{"@id":"https:\/\/regask.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/regask.com\/health-canada-review-pharma-advertising-code\/#primaryimage"},"image":{"@id":"https:\/\/regask.com\/health-canada-review-pharma-advertising-code\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2024\/02\/proposed-changes-pharmaceutical-advertising-advisory-board-paab-code-health-canada-review.png","datePublished":"2024-02-21T11:23:25+00:00","dateModified":"2024-11-05T12:53:46+00:00","description":"Apprenez-en plus sur l&#039;acceptation \u00e9largie des preuves du monde r\u00e9el, les ajustements propos\u00e9s aux crit\u00e8res des essais cliniques... Lire la suite | RegASK","inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/regask.com\/health-canada-review-pharma-advertising-code\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/regask.com\/health-canada-review-pharma-advertising-code\/#primaryimage","url":"https:\/\/regask.com\/wp-content\/uploads\/2024\/02\/proposed-changes-pharmaceutical-advertising-advisory-board-paab-code-health-canada-review.png","contentUrl":"https:\/\/regask.com\/wp-content\/uploads\/2024\/02\/proposed-changes-pharmaceutical-advertising-advisory-board-paab-code-health-canada-review.png","width":1600,"height":1200,"caption":"Proposed Changes Pharmaceutical Advertising Advisory Board Paab Code Health Canada Review"},{"@type":"WebSite","@id":"https:\/\/regask.com\/#website","url":"https:\/\/regask.com\/","name":"RegASK","description":"Le syst\u00e8me d&#039;exploitation d&#039;IA r\u00e9glementaire pour les \u00e9quipes performantes","publisher":{"@id":"https:\/\/regask.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/regask.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/regask.com\/#organization","name":"RegASK","url":"https:\/\/regask.com\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/regask.com\/#\/schema\/logo\/image\/","url":"https:\/\/regask.com\/wp-content\/uploads\/2024\/10\/RegASK-Logo-Dark-Round.png","contentUrl":"https:\/\/regask.com\/wp-content\/uploads\/2024\/10\/RegASK-Logo-Dark-Round.png","width":401,"height":401,"caption":"RegASK"},"image":{"@id":"https:\/\/regask.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/","https:\/\/x.com\/ASKRegASK","https:\/\/www.linkedin.com\/company\/RegASK\/","https:\/\/www.youtube.com\/@RegASK","https:\/\/www.crunchbase.com\/organization\/regask","https:\/\/www.bloomberg.com\/profile\/company\/1691237D:SP","https:\/\/pitchbook.com\/profiles\/company\/265004-02","https:\/\/www.cbinsights.com\/company\/RegASK","https:\/\/vimeo.com\/RegASK"],"legalName":"RegASK PTE. LTD.","foundingDate":"2018","slogan":"Empowering Smarter Regulatory Decisions","description":"Plateforme d&#039;intelligence artificielle multi-agents pour la veille r\u00e9glementaire et l&#039;orchestration des flux de travail dans le secteur des sciences de la vie et des produits de consommation. RegASK combine des LLM verticaux, une architecture d&#039;IA multi-agents et une communaut\u00e9 mondiale de plus de 1\u00a0800 experts pour fournir une veille r\u00e9glementaire, une analyse d&#039;impact, l&#039;automatisation des processus de conformit\u00e9 et des r\u00e9sultats pr\u00eats pour l&#039;audit dans plus de 160 pays.","areaServed":"Worldwide","founder":{"@type":"Person","name":"Caroline Shleifer","jobTitle":"Founder & CEO"},"address":{"@type":"PostalAddress","streetAddress":"79 Science Park Drive, #06-01, Cintech IV","addressLocality":"Singapore","postalCode":"118264","addressCountry":"SG"},"contactPoint":{"@type":"ContactPoint","telephone":"+65 6817 6290","contactType":"customer service","availableLanguage":["English","French","Japanese","Spanish","Chinese","German"]},"numberOfEmployees":{"@type":"QuantitativeValue","minValue":50,"maxValue":100},"knowsAbout":["Regulatory Intelligence","Regulatory Compliance","Regulatory Affairs","Workflow Orchestration","Life Sciences Regulation","Consumer Products Regulation","AI-Driven Compliance"],"hasCertification":[{"@type":"Certification","name":"ISO\/IEC 42001:2023"},{"@type":"Certification","name":"ISO\/IEC 27001:2022"},{"@type":"Certification","name":"ISO\/IEC 27701"},{"@type":"Certification","name":"ISO\/IEC 27018:2019"},{"@type":"Certification","name":"SOC 2 Type II"}]},{"@type":"Person","@id":"https:\/\/regask.com\/#\/schema\/person\/c1d261e8dcf7b1c30b2c4f2c119df42d","name":"Beno\u00eet Trouwaert"}]}},"_links":{"self":[{"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/posts\/4883","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/users\/39"}],"replies":[{"embeddable":true,"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/comments?post=4883"}],"version-history":[{"count":0,"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/posts\/4883\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/media\/7393"}],"wp:attachment":[{"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/media?parent=4883"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/categories?post=4883"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/tags?post=4883"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}